Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Cancer-Related Fatigue: Causes and Current Treatment Options157
Treatment of Relapsed Acute Myeloid Leukemia125
Targeted Therapies in Advanced Gastric Cancer111
Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines53
Tumor Treating Fields in the Management of Patients with Malignant Gliomas44
Metabolic Aspects of Anthracycline Cardiotoxicity43
Dedifferentiated Liposarcoma: Systemic Therapy Options43
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma39
Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape37
Advances in the Treatment of Cardiac Amyloidosis36
Models of Integration of Specialized Palliative Care with Oncology34
The Effect of Prognostic Communication on Patient Outcomes in Palliative Cancer Care: a Systematic Review33
Systemic Therapy for Metastatic Pancreatic Cancer32
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates32
Evolving Definitions of Palliative Care: Upstream Migration or Confusion?31
Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations30
Opioids and Cancer Mortality30
The Importance of Prognostication: Impact of Prognostic Predictions, Disclosures, Awareness, and Acceptance on Patient Outcomes29
Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy29
When to Integrate Palliative Care in the Trajectory of Cancer Care28
New Treatment Options for Advanced Biliary Tract Cancer27
PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma26
Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations25
Immunotherapy in Hepatocellular Carcinoma25
Optimal Strategies for Colorectal Cancer Screening24
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma24
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer24
Optimal Management of Corticosteroids in Patients with Intracranial Malignancies22
Contemporary Management of Anaplastic Thyroid Cancer22
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults22
Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy21
Current Treatment of Melanoma Brain Metastasis21
Curative-Intent Therapies in Localized Hepatocellular Carcinoma21
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms20
BRAF Heterogeneity in Melanoma20
Defining and Targeting BRAF Mutations in Solid Tumors20
Oncolytic Viruses for the Treatment of Metastatic Melanoma19
Cardiovascular Toxicities of Androgen Deprivation Therapy19
Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer19
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past19
Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?18
Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia18
Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone18
Janus Kinase Inhibitors and Non-Melanoma Skin Cancer17
Progress on Management of Penile Cancer in 202016
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer16
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment16
Nausea and Vomiting in Advanced Cancer16
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy16
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer16
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives16
Role of TKI for Metastatic Osteogenic Sarcoma15
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma15
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy15
Systemic Options for Malignant Peripheral Nerve Sheath Tumors15
The Evolving Landscape of HER2-Directed Breast Cancer Therapy15
Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation15
Current Status of CAR T Cell Therapy for Leukemias15
Appropriate Selection of PARP Inhibitors in Ovarian Cancer15
The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature14
Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors14
Evaluation and Management of Sleep and Circadian Rhythm Disturbance in Cancer14
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?14
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies14
Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?14
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma14
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?14
Leveraging Social Media for Cardio-Oncology13
Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma13
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms13
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy13
Constipation in Cancer Patients — an Update of Clinical Evidence13
Recent Advances in the Management of Acute Lymphoblastic Leukaemia13
Symptom Management in Pancreatic Cancer13
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients13
Understanding and Supporting Informal Cancer Caregivers13
Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma12
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy12
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches12
Treatment Strategies for Oligometastatic Breast Cancer12
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations12
HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles12
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms12
Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy12
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?11
Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors11
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities11
Family Meetings in Palliative Care: Benefits and Barriers11
Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development11
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients11
Neoadjuvant Immunotherapy for Locally Advanced Melanoma11
Exercise Training for Cancer Survivors11
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy11
Strategies to Prevent Cardiotoxicity11
How Effective Is Palliative Care in Improving Patient Outcomes?11
TRK Inhibitors in Non-Small Cell Lung Cancer11
The Benefits of Olanzapine in Palliating Symptoms11
Management of Laryngeal Dysplasia and Early Invasive Cancer10
New Treatment Options for Older Patients with Acute Myeloid Leukemia10
Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck10
Drug Repurposing in Medulloblastoma: Challenges and Recommendations10
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?10
Systemic Therapy for Lung Cancer Brain Metastases10
Treatment personalization in gastrointestinal neuroendocrine tumors10
Patient Selection and Toxicities of PRRT for Metastatic Neuroendocrine Tumors and Research Opportunities10
Treating Chronic Pain with Buprenorphine—The Practical Guide10
Hereditary Syndromes in Neuroendocrine Tumors10
Surgical Management of Skull Base and Spine Chordomas10
The Role of Oncoplastic Surgery for Breast Cancer10
Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities10
Immunotherapy and Biomarkers in Sarcoma10
New Approaches to Myelodysplastic Syndrome Treatment10
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure10
BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia10
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer10
Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials10
Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer9
Defining and Treating Borderline Resectable Pancreatic Cancer9
Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas9
Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments9
Anatomic and Functional Imaging of Neuroendocrine Tumors9
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis9
Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions9
Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma9
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma9
Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors9
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now9
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer9
Patient Spirituality as a Component of Supportive Care: Assessment and Intervention9
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)9
Advanced Acral Melanoma Therapies: Current Status and Future Directions9
0.08362603187561